Prostate-derived ETS factor regulates epithelial-to-mesenchymal transition through both SLUG-dependent and independent mechanisms

Genes and Cancer

Volumn 2, Issue 2, 2011, Pages 120-129

  Findlay, Victoria J ^a,b   Turner, David P ^a,b   Yordy, John S ^a,b,c   McCarragher, Brent ^a,b,d   Shriver, Marey R ^a,b,e   Szalai, Gabor ^a,b,d   Watson, Patricia M ^a,b   Larue, Amanda C ^a,b   Moussa, Omar ^a,b   Watson, Dennis K ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

Author keywords

Breast cancer; Epithelial to mesenchymal transition; ETS transcription factors; PDEF; SLUG

Indexed keywords

TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR SLUG; UVOMORULIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 79960035699     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911410424     Document Type: Article

References (39)

1. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005;41(16):2462-78.
2. Watson DK, Turner DP, Scheiber MN, Findlay VJ, Watson PM. ETS transcription factor expression and conversion during prostate and breast cancer progression. Open Cancer J. 2010;3:24-39.
3. Ghadersohi A, Sood AK. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin Cancer Res.2001;7(9):2731-8.
4. Thompson HG, Harris JW, Wold BJ, Lin F, Brody JP. p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene. 2003;22(15):2322-33.
5. Feldman RJ, Sementchenko VI, Gayed M, Fraig MM, Watson DK. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 2003;63(15):4626-31.
6. Ghadersohi A, Pan D, Fayazi Z, Hicks DG, Winston JS, Li F. Prostatederived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo. Breast Cancer Res Treat. 2007;102(1):19-30.
7. Gu X, Zerbini LF, Otu HH, et al. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res. 2007;67(9):4219-26.
8. Turner DP, Moussa O, Sauane M, Fisher PB, Watson DK. Prostatederived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res.2007;67(4):1618-25.
9. Ghadersohi A, Odunsi K, Zhang S, et al. Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients. Int J Cancer. 2008;123(6):1376-84.
10. Moussa O, Turner DP, Feldman RJ, et al. PDEF is a negative regulator of colon cancer cell growth and migration. J Cell Biochem. 2009;108(6):1389-98.
11. Johnson TR, Koul S, Kumar B, et al. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF. Mol Cancer. 2010;9:148.
12. Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS. Novel role for PDEF in epithelial cell migration and invasion. Cancer Res. 2005;65(24):11572-80.
13. Turner DP, Findlay VJ, Kirven AD, Moussa O, Watson DK. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell.2008;19(9):3745-57.
14. Schaefer JS, Sabherwal Y, Shi HY, et al. Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression. J Biol Chem. 2010;285(15):11258-69.
15. Findlay VJ, Turner DP, Moussa O, Watson DK. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008;68(20):8499-506.
16. Trelstad RL, Hay ED, Revel JD. Cell contact during early morphogenesis in the chick embryo. Dev Biol. 1967;16(1):78-106.
17. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871-90.
18. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3(3):155-66.
19. Storci G, Sansone P, Trere D, et al. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol.2008;214(1):25-37.
20. Jethwa P, Naqvi M, Hardy RG, et al. Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol. 2008;14(7):1044-52.
21. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008;68(4):989-97.
22. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factorbeta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell. 2001;12(1):27-36.
23. Lindley LE, Briegel KJ. Molecular characterization of TGFbetainduced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. Biochem Biophys Res Commun.2010;399(4):659-64.
24. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epitheliumto- mesenchyme transition. J Cell Sci. 2005;118(Pt 5):873-87.
25. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274-84.
26. Talmadge JE, Fidler IJ. AACR Centennial Series. The biology of cancer metastasis: historical perspective. Cancer Res. 2010;70(14): 5649-69.
27. Feldman RJ, Sementchenko VI, Watson DK. The epithelialspecific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res.2003;23(3A):2125-31.
28. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993;53(7):1696-701.
29. Umbas R, Isaacs WB, Bringuier PP, et al. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res. 1994;54(14):3929-33.
30. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645-54.
31. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherincadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol. 2003;163(4):847-57.
32. Alves CC, Carneiro F, Hoefler H, Becker KF. Role of the epithelialmesenchymal transition regulator Slug in primary human cancers. Front Biosci. 2009;14:3035-50.
33. Feng XH. The changing faces of cancer cells. Nat Rev Mol Cell Biol.2010;11(7):466.
34. Radisky DC, LaBarge MA. Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell. 2008;2(6):511-2.
35. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell.2008;133(4):704-15.
36. Blick T, Hugo H, Widodo E, et al. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia. 2010;15(2):235-52.
37. Nowak DE, Tian B, Brasier AR. Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques. 2005;39(5):715-25.
38. Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo PH, Mignotte V. Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte- specific genes. Blood. 1996;87(11):4678-85.
39. Mignotte V, Vigon I, Boucher de Crevecoeur E, Romeo PH, Lemarchandel V, Chretien S. Structure and transcription of the human c-mpl gene (MPL). Genomics. 1994;20(1):5-12.